USPTO serial 79291398
ZIONEXA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 2, 2021
- Examiner
- CIANCI, RYAN MICHAEL
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ZIONEXA?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
Owner
GE Healthcare Limited
GB
ZIONEXA
FR
ZIONEXA
FR
ZIONEXA
FR
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Radiopharmaceuticals for treating oncological diseases; in-vivo diagnostic markers used for detection and monitoring of oncological therapy; pharmaceutical preparations for human and veterinary use for treating oncological diseases; biological preparations for medical use for treating cancer; chemical preparations for medical use for treating cancer; food supplements and nutritional supplements for medical use; dietetic food and beverages for medical and pharmaceutical use; homeopathic supplements; plant therapy compositions, namely, medicinal teas; sanitary tampons for medical purposes; medicated bath preparations; dietetic beverages for medical use; chemical diagnostic reagents for medical use, namely, biomarkers; products for personal hygiene for medical purposes, namely, medicated douching preparations; medical plasters; medical dressings; surgical and medical dressings | ACTIVE | — |
| 010 | Medical devices for diagnostic use for administering contrast media; medical diagnostic instruments for detecting cancer; surgical apparatus and instruments; medical instruments for collection of human body fluids; kits primarily comprised of surgical instruments; containers for medical cancer samples; medicine administering tubes for surgical applications; container holders specifically adapted for holding medical samples; medicine administering tubes for medical applications; syringes for medical use; syringe needles for medical use; containers especially adapted for depositing medical syringes | ACTIVE | — |
| 041 | Training services in the fields of healthcare, pharmaceuticals, medical research, pharmaceutical, and medicine development; publication of books and texts other than advertising texts in the pharmaceutical, medical and health fields; arranging and conducting of colloquiums, conferences, congresses, seminars in the pharmaceutical, medical and health fields | ACTIVE | — |
| 042 | Development of pharmaceutical products; pharmaceutical research and development; testing in the form of quality control for others of pharmaceutical products; carrying out clinical trials for pharmaceutical products for others; scientific research regarding medicine; computer bio-informatic system, chemical and biological analysis; research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological and bio-informatic research services in the field of chemical, biological and pharmaceutical products; software design and development in the field of pharmaceutical, health and medical research; Providing medical and scientific research information in the field of pharmaceutical products and clinical trials; research on chemical reagents for medical use, namely, biomarkers; design of databases in the field of pharmaceutical research and development, medicine, genetics and clinical trials | ACTIVE | — |
| 044 | Dispensing of pharmaceuticals services; pharmaceutical advice; medical services; medical information services; providing medical information; information services on the treatment of diseases via an awareness program; providing information with respect to pharmaceuticals | ACTIVE | — |
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 2, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 23, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 31, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 24, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 19, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 11, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 30, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 30, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 30, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 30, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 30, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 28, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 3, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 3, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 2, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 2, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 15, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 15, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 25, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 14, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 9, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 7, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 3, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 18, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 14, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 13, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |